{"id":3746,"date":"2018-01-22T17:02:22","date_gmt":"2018-01-22T22:02:22","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3746"},"modified":"2018-01-22T17:03:31","modified_gmt":"2018-01-22T22:03:31","slug":"secondaries-announced-1-22-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1-22-18\/","title":{"rendered":"Secondaries Announced 1.22.18"},"content":{"rendered":"<h4><strong>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n<p>If having\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/ipo-boutique-announces-new-secondary-alert-service\/#sthash.HnSepMmy.dpbs\" target=\"_blank\"><strong>real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,<a style=\"border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: #333333; color: #333333; text-decoration: none;\" href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">\u00a0inquire about a subscription today!<\/a><\/p>\n<p>Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n<p>Company: Adamas Pharmaceuticals, Inc.<br \/>\nSymbol: ADMS<br \/>\nPrice: Last Trade $40.79<br \/>\nTrade Date: 1\/24<br \/>\nShares: 2.1 million ($85m cash raise)<br \/>\nUnderwriter(s): BofA Merrill Lynch, Leerink, Evercore ISI<br \/>\nDescription: Adamas is a pharmaceutical company committed to developing and commercializing products and product candidates for the treatment of chronic neurological disorders.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Stemline Therapeutics, Inc.<br \/>\nSymbol: STML<br \/>\nPrice: Last Trade $14.25<br \/>\nTrade Date: 1\/24<br \/>\nShares: 3.7 million<br \/>\nUnderwriter(s): J.P. Morgan, Cowen and Company<br \/>\nDescription: Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics.<br \/>\nRating =\u00a0<strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Ultragenyx Pharmaceuticals, Inc.<br \/>\nSymbol: RARE<br \/>\nPrice: Last Trade $53.39<br \/>\nTrade Date: 1\/24<br \/>\nShares: 3.3 million ($175m cash raise)<br \/>\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Goldman Sachs, Cowen and Company<br \/>\nDescription: Ultragenyx is a biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Jamba, Inc. &#8212; Block<br \/>\nSymbol: JMBA<br \/>\nPrice: Last Trade $9.14<br \/>\nTrade Date: 1\/23<br \/>\nShares: 2.1 million<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s): Morgan Stanley<br \/>\nDescription: Jamba, Inc., through its subsidiary, Jamba Juice Company, owns, operates, and franchises Jamba Juice stores. Its restaurants provide specialty food and beverage offerings, such as whole fruit smoothies, fresh squeezed juices and juice blends, and whole fruit and soymilk or fresh Greek yogurt, as well as various food items, including hot oatmeal, hot beverages, breakfast wraps, sandwiches, Artisan Flatbreads, baked goods, and snacks.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[729,1458,15,1029],"class_list":["post-3746","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-adms","tag-jmba","tag-rare","tag-stml"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3746"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3746\/revisions"}],"predecessor-version":[{"id":3748,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3746\/revisions\/3748"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}